Black Friday Weekend Sale : Save 30% or more on all our guides and exclusive bundle offers. Learn more

Studies related to Migraine and Vitamin B2

Riboflavin Prophylaxis In Pediatric And Adolescent Migraine

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 41
Sex Both Genders
Age Range 7-12, 13-17
Notes for this study:
Supplementation of riboflavin in youth (pediatric and adolescent subjects) at either 200mg or 400mg a day over the course of 3-6 months appeared to be beneficial in improving symptoms of migraines.

The amount of subjects in the riboflavin group reported more than a halving of migraine frequency reached 68.4%, whereas average intensity reported from migraines was reduced 21% compared to baseline (no significant change noted with placebo).

Full details on all 7 studies are available to Examine members — 30% off during our Black Friday sale.

Already a member? Log in now to access.